IDH1 and non-small cell lung carcinoma: analyzed IDH1/2 mutations in 1924 NSCLC specimens (92% adenocarcinoma) using next-generation sequencing and identified IDH1/2 mutations in nine (0.5%) adenocarcinomas (12).